Odonate Therapeutics (ODTC) Financials

$50,000.00

$49,998.50 (3,333,233.33%)

As on 08-Sep-2026 09:30EDT

Market cap

$53 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

7.3

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.02	0.34	1.05	0.87	0.38	0.35
Gross Profit	-0.02	-0.34	-1.05	-0.87	-0.38	-0.35
Operating Expenses	0.80	3.58	45.77	126.56	114.93	90.76
Operating Profit (EBIT)	-0.82	-3.92	-46.82	-127.43	-114.93	-90.76
Other Income	--	--	--	--	--	--
Profit before Tax	9.44	9.64	-68.32	-126.35	-111.83	-88.96
Provision for Tax	2.12	-33.30	0.81	0.24	-3.11	1.80
Profit after Tax (Net Income)	7.33	42.94	-68.32	-126.35	-111.83	-88.96
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-126.35	-111.83	-88.96

Liabilities ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	108.12	100.85	59.26	136.15	162.30	124.00
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.82	2.30	3.90	4.67	1.75	0.46
Current Liabilities	0.51	0.58	15.83	27.07	24.78	18.21
Total Liabilities	110.45	103.73	79.00	167.89	188.83	142.67

Assets ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	53.37	55.46	3.85	8.01	4.90	2.87
Current Assets	57.09	48.27	75.15	159.87	183.93	139.80
Total Assets	110.45	103.73	79.00	167.89	188.83	142.67
Total Debt*	2.30	2.77	4.67	5.33	2.06	--
Net Current Assets	56.58	47.69	59.32	132.80	159.15	121.59

Cashflow ($ Mln)	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	8.74	1.80	-75.73	-113.13	-96.64	-67.09
Cash Flow from Investing Activities	20.15	-58.35	-0.03	-0.43	-0.17	-1.91
Cash from Financing Activities	-0.20	-1.62	-12.75	90.37	138.68	10.20
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	6,659.09	39,036.36	-62,104.55	-90,250.00	-101,659.09	-98,844.44
Cash EPS ($)	6,678.18	39,137.27	-61,670.91	-89,932.14	-101,312.73	-98,455.56
Adjusted Book Value ($)	98,291.82	91,680.91	53,876.36	97,246.43	147,545.45	137,782.22
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	7,945.45	1,631.82	-68,840.91	-80,807.14	-87,852.73	-74,548.89
Free Cash Flow per Share ($)	7,945.45	1,631.82	-68,864.55	-81,115.71	-88,003.64	-76,667.78

Profitability Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	6.84	51.26	-66.52	-82.63	-77.56	-55.60
ROE (%)	7.01	53.64	-69.92	-84.67	-78.12	-55.60
ROA (%)	6.84	47.00	-55.34	-70.84	-67.47	-51.40
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-2.01	114.11	45.93	-12.99	-25.70	-171.68
Net Profit Growth (%)	-82.94	162.86	45.93	-12.99	-25.70	-171.68
EPS Growth (%)	-0.83	1.63	0.31	0.11	-0.03	-1.11
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	0.00	0.00	0.00	0.00	0.00	0.00
Price / Book Value	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-5.78	-4.55	0.95	1.21	1.60	1.57
Close Price ($)	1.50	3,500.00	2,700.00	38,400.00	64,900.00	28,160.00
High Price ($)	4,840.00	3,960.00	56,820.00	92,999.80	87,500.00	64,000.00
Low Price ($)	1.50	1,615.40	2,620.00	25,120.00	25,880.00	23,080.00
Market Cap ($ Cr)	--	--	--	--	--	--

Solvency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	0.02	0.03	0.08	0.04	0.01	--
Short term debt to equity ratio	0.00	0.00	0.01	0.00	0.00	--
Current Ratio	111.72	82.66	4.75	5.91	7.42	7.68
Quick Ratio	--	--	--	--	--	--
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	226.11	169.81	2,512.96	6,245.15	12,635.16	7,868.01
Cash Conversion Cycle	--	--	--	--	--	--